Natural Killer cells face a remarkable biological problem. They must continuously distinguish healthy cells from stressed, infected or malignant cells and decide which should be destroyed. Increasing evidence suggests that p53 participates directly in coordinating that decision. A recent review in Frontiers in Immunology brings together evidence that p53 affects not only the internal fate of a damaged target cell, but also the signals by which Natural Killer cells recognize, engage and ultimately destroy it.
This creates an interesting question for Codondex. If p53 coordinates several different components of the NK-target interaction at the same time, could the unusually dense repeat structures that Codondex detects within TP53 help identify genomic regions involved in regulating that coordination? We describe these structures as High-Density Nested Repeat Fields, or HDNRFs: regions in which repeated, overlapping and nested short sequences become unusually concentrated. HDNRFs are not simply conventional tandem repeats. They represent a broader sequence geography that becomes visible when DNA is examined simultaneously across multiple sequence lengths and positions.
The Codondex methodology approaches this problem without first needing to know the biological function of the sequence. It divides genetic sequence into overlapping components, preserves their relative positions and relationships, and identifies sequence combinations that recur or associate unusually strongly. The important distinction is that Codondex can identify unusual sequence architecture first and ask what that architecture means biologically afterwards. The progression is therefore from sequence, to pattern, to biological association and finally, if experimentally demonstrated, to mechanism.
We have already seen an intriguing example of this process within TP53. In an earlier Codondex analysis, the algorithm selected 28-nucleotide sequences constructed from a set of shorter key sequences and found a remarkable concentration of recurring sequence components within a very short region of TP53. That analysis converged on the intron 3 region containing the known PIN3 polymorphism, or Polymorphism Intron 3. PIN3 is a 16-base-pair duplication within a region of TP53 already known from conventional research to possess unusual structural and regulatory characteristics, including G-rich sequence capable of participating in G-quadruplex formation and regulation of TP53 RNA processing.
The importance of the PIN3 observation is not that Codondex discovered PIN3 itself. The polymorphism was already known. What was significant was the route by which Codondex arrived there. The algorithm was not instructed to search for PIN3, a G-quadruplex or a known p53 regulatory element. It arrived at the region because of an unusual concentration of relationships within the underlying sequence. Biology then independently provided a reason why that region might matter. That is an early example of the utility we are now trying to test more systematically with HDNRFs: whether unusual repeat geography can lead us to biologically important regulatory locations before we understand why those locations are important.
A second observation has made the p53 question considerably more interesting. In our tumour-section sequence data, the Codondex-selected sequences were compared with multiple immune measurements, including Chromium-release cytotoxicity under pNK, IL-2-stimulated pNK and sNK conditions, together with IFN-γ, cell-number and Elispot measurements. The experimental data therefore allow sequence characteristics identified independently by the algorithm to be compared against several different manifestations of NK-cell behaviour.
In repeated analyses of these data, pNK has continued to emerge as one of the most interesting and apparently most correlated biological candidates. This has occurred when the data of 48 tumour-sections were approached in different ways, including ranking the occurrence of duplicate algorithm-selected sequences and examining shorter repeated, overlapping and tandem-repeat relationships within the selected 28-base sequences. When those independent sequence rankings were compared with the experimental measurements, pNK repeatedly returned as a candidate association. This recurrence is more interesting because it is not simply tracking the assay with the largest numerical values.
Indeed, the unstimulated pNK experimental signal is often remarkably weak. In the Chromium pNK measurements many tumour sections are at or close to zero, although a smaller number of sections show substantially greater cytotoxicity. The corresponding pNK IFN-γ measurements are even more striking, with many samples recording zero and only a subset producing detectable values. In contrast, IL-2-stimulated pNK and sNK measurements frequently produce much larger absolute responses. Yet despite this weak unstimulated signal, pNK has repeatedly surfaced when the Codondex sequence characteristics are ranked against the experimental results.
That distinction could be important. If the relationship were simply that more repeat sequence generated more general immune activity, one might expect the strongest associations to appear consistently in the assays producing the largest absolute responses. That is not obviously what we are seeing. Instead, an intrinsically weak pNK phenotype appears repeatedly when the sequence data are interrogated using different measures of repeat structure. At present this remains an exploratory observation rather than proof of a biological relationship, but it suggests that the algorithm may be detecting something associated with the underlying susceptibility of the target cell to natural NK surveillance, before that response is amplified artificially by IL-2 stimulation.
The p53 literature offers a plausible biological framework for explaining why such a relationship might exist. p53 appears capable of translating the internal stress state of a target cell into an external immune-recognition state. Wild-type p53 can increase expression of ULBP1 and ULBP2, activating ligands recognized by NKG2D on NK cells. p53 can influence PVR/CD155, which participates in DNAM-1 signalling, and ICAM-1, which helps stabilize the interaction between an NK cell and its target. In some experimental systems p53 activation also alters inhibitory MHC-I signalling. The intracellular state of p53 can therefore affect whether the exterior of the target cell tells an NK cell, in effect, that something is wrong.
The same p53 response can also influence whether the target dies once it has been recognized. p53 participates in BAX-mediated mitochondrial apoptosis and intersects with pathways involving granzyme activity, Fas and TRAIL death receptors. The same regulatory system that contributes to making the abnormal cell recognizable can therefore also make it more susceptible to the execution mechanisms used by the NK cell. p53-dependent signalling can additionally regulate chemokines such as CCL2 and influence the inflammatory environment controlling recruitment of NK cells to the target.
This suggests that p53 is not controlling one isolated NK signal. It may be coordinating several requirements for successful immune surveillance. The abnormal cell must first become recognizable. An NK cell must encounter it. Activating signals must overcome inhibitory signals. Stable NK-target contact must be achieved. The target must then remain susceptible to the apoptotic machinery delivered by the NK cell. p53 appears capable of influencing several of these conditions within the same biological response.
We describe this concept as p53-driven NK-target synchronicity. The word synchronicity is useful because the ultimate NK cytotoxicity measurement may be the visible end point of several variables moving together. A weak pNK result therefore does not necessarily imply a biologically unimportant relationship. If unstimulated pNK represents the basal ability of the NK cell to identify and eliminate an abnormal target, even a relatively small signal may contain considerable information about whether the underlying recognition machinery is properly aligned.
Viewed in this context, the repeated Codondex association with pNK becomes particularly interesting. The question is no longer simply whether a p53 repeat sequence correlates with the magnitude of NK cytotoxicity. It is whether an HDNRF identifies a genomic state associated with the probability that the target cell and NK cell become correctly synchronized. That could explain why a relatively weak pNK phenotype repeatedly appears when sequence characteristics are ranked in different ways. The algorithm may not be identifying the magnitude of an immune response so much as a genomic condition influencing whether the target is naturally visible to the NK cell in the first place.
This also produces a much more precise experimental hypothesis. If a p53 HDNRF is genuinely associated with NK-target synchronicity, it should not correlate only with the final Chromium pNK measurement. The variables between the sequence and the cytotoxicity result should also move together. Tumour sections ranked according to the relevant HDNRF signal could therefore be measured for functional p53 activity, ULBP1 and ULBP2 expression, PVR/CD155, ICAM-1, BAX and apoptotic competence, together with NKG2D and DNAM-1 engagement, NK-cell CD107a degranulation, IFN-γ production and direct target-cell killing.
The important result would not be one statistically significant relationship. It would be a coherent progression in which the HDNRF state predicts p53 state, p53 state predicts the target-cell recognition phenotype, and that phenotype predicts the pNK response. If these variables rise and fall together across the same tumour sections, it would provide a mechanistic explanation for an association that has so far appeared computationally.
Temporal experiments could test the relationship even more directly. Controlled activation of wild-type p53 should first change p53-responsive transcription, followed by changes in NK-recognition ligands and apoptotic competence, and ultimately by a measurable change in NK engagement and killing. Suppressing or removing functional p53 should disrupt at least part of that progression. Restoring p53 should restore it. Such an experiment would allow the apparent synchronicity to be observed rather than inferred from static correlations.
The decisive experiment, however, concerns the repeat field itself. If an HDNRF is merely a marker, it may reliably identify the biological state without causing it. If it is regulatory, directly altering the repeat field should alter the system. CRISPR-based sequence changes or targeted epigenetic manipulation of a candidate p53 HDNRF could therefore test whether changing its architecture alters p53 transcription, RNA processing or functional activity and whether those effects subsequently propagate through NK-target recognition and cytotoxicity.
PIN3 provides an important precedent for why this approach deserves investigation. Codondex sequence analysis independently converged on a densely repetitive TP53 region that conventional molecular biology had already identified as structurally and functionally unusual. The pNK results provide a second, independent clue. Different approaches to ranking the tumour-section sequence data have repeatedly pointed towards an NK phenotype that, paradoxically, is one of the weakest in absolute experimental magnitude. Together these observations raise the possibility that Codondex is detecting something more fundamental than a simple relationship between sequence abundance and biological response.
The hypothesis now becomes testable. If the relevant p53 HDNRFs vary together with p53 functional state, NK-activating ligand expression, NK-target engagement and unstimulated pNK cytotoxicity, then the previously observed pNK association acquires a mechanistic explanation. If altering the HDNRF changes that sequence of events, the implication becomes substantially stronger.
Codondex was designed to find relationships in genetic sequence before we necessarily know what those relationships mean. PIN3 showed how an algorithmically identified concentration of repeat relationships could converge on known p53 regulatory biology. The repeated pNK association suggests that these sequence patterns may also intersect with immune function. The p53–NK literature now gives us a biological framework capable of connecting those two observations.
The next research question is therefore no longer simply whether p53 contains unusual repeat fields. It is whether some of those fields participate in the extraordinary coordination by which a stressed or malignant cell becomes visible as a target, and a Natural Killer cell recognizes that signal and responds.
No comments:
Post a Comment